Usana Health Sciences (USNA) Gross Profit (2016 - 2026)
Usana Health Sciences has reported Gross Profit over the past 17 years, most recently at $190.8 million for Q2 2026.
- Quarterly Gross Profit fell 3.2% to $190.8 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $718.1 million through Apr 2026, up 1.76% year-over-year, with the annual reading at $724.4 million for FY2026, 4.49% up from the prior year.
- Gross Profit was $190.8 million for Q2 2026 at Usana Health Sciences, up from $176.8 million in the prior quarter.
- Over five years, Gross Profit peaked at $294.5 million in Q1 2022 and troughed at $161.0 million in Q3 2024.
- The 5-year median for Gross Profit is $185.2 million (2024), against an average of $191.8 million.
- Year-over-year, Gross Profit crashed 38.37% in 2022 and then increased 7.61% in 2025.
- A 5-year view of Gross Profit shows it stood at $181.5 million in 2022, then dropped by 1.52% to $178.8 million in 2023, then fell by 2.07% to $175.1 million in 2024, then decreased by 5.83% to $164.9 million in 2025, then increased by 15.73% to $190.8 million in 2026.
- Per Business Quant, the three most recent readings for USNA's Gross Profit are $190.8 million (Q2 2026), $176.8 million (Q1 2026), and $164.9 million (Q3 2025).